You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR PAMELOR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PAMELOR

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00062738 ↗	Treatment of Depression in Parkinson's Disease Trial	Completed	GlaxoSmithKline	Phase 2	2003-06-01	The goal of this study is to evaluate the effectiveness and safety of two antidepressants--nortriptyline and paroxetine, compared to placebo in patients with Parkinson's disease and depression.
NCT00062738 ↗	Treatment of Depression in Parkinson's Disease Trial	Completed	Rutgers, The State University of New Jersey	Phase 2	2003-06-01	The goal of this study is to evaluate the effectiveness and safety of two antidepressants--nortriptyline and paroxetine, compared to placebo in patients with Parkinson's disease and depression.
NCT00547703 ↗	Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia	Terminated	Cleveland Clinic Florida	N/A	2008-02-01	The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia.
NCT00547703 ↗	Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia	Terminated	The Cleveland Clinic	N/A	2008-02-01	The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia.
NCT00742573 ↗	Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics	Completed	National Institute of Mental Health (NIMH)	Phase 2	2008-08-01	This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.
NCT00742573 ↗	Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics	Completed	New York State Psychiatric Institute	Phase 2	2008-08-01	This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PAMELOR

Condition Name

Chart
Table

Condition Name for PAMELOR
Intervention	Trials
Depression	2
Major Depressive Disorder	2
Geriatric Depression	1
Idiopathic Gastroparesis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PAMELOR
Intervention	Trials
Depression	5
Depressive Disorder	4
Depressive Disorder, Major	3
Small Cell Lung Carcinoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PAMELOR

Trials by Country

Map
Table

Trials by Country for PAMELOR
Location	Trials
United States	14
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PAMELOR
Location	Trials
California	2
New York	2
Missouri	1
Washington	1
Maryland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PAMELOR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PAMELOR
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	1
Phase 2	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PAMELOR
Clinical Trial Phase	Trials
Completed	5
Terminated	1
Withdrawn	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PAMELOR

Sponsor Name

Chart
Table

Sponsor Name for PAMELOR
Sponsor	Trials
National Institute of Mental Health (NIMH)	2
Central Michigan University	1
Sheppard Pratt Health System	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PAMELOR
Sponsor	Trials
Other	9
NIH	4
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.